Percutaneous intravenous injection in neonatal mice

Laboratory Animal Science

Volumn 49, Issue 3, 1999, Pages 328-330

  Sands, Mark S ^a   Barker, Jane E ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; EXPERIMENTAL ANIMAL; EXPERIMENTAL SURGERY; INJECTION SITE; LABORATORY TEST; MOUSE; NEWBORN; NONHUMAN;

ANIMALS; ANIMALS, NEWBORN; CATHETERIZATION; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED STRAINS; TEMPORAL MUSCLE; VEINS;

EID: 0033020597     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Sly, W. S., B. A. Quinton, W. H. McAallister, et al. 1973. β-Glucuronidase deficiency: report of clinical, radiologic and biochemical features of a new mucopolysaccharidosis. J. Pediatr. 82:249-257.
2. Birkenmeier, E. H., M. T. Davisson, W. G. Beamer, et al. 1989. Murine mucopolysaccharidosis VII - characterization of a mouse with β-glucuronidase deficiency. J. Clin. Invest. 68: 1258-1266.
3. Sands, M. S., J. E. Barker, C. A. Vogler, et al. 1993. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab. Invest. 68: 676-686.
4. Birkenmeier, E. H., J. E. Barker, C. A. Vogler, et al. 1991. Increased life span and correction of the metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 78:3081-3092.
5. Sands, M. S., L. C. Erway, C. A. Vogler, et al. 1995. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII. Blood 86:2033-2040.
6. Vogler, C. A., M. S. Sands, A. Higgins, et al. 1993. Enzyme replacement with recombinant β-glucuronidase in the newborn MPS VII mouse. Pediatr. Res. 34:837-840.
7. Sands, M. S., C. Vogler, J. W. Kyle, et al. 1994. Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J. Clin. Invest. 93:2324-2331.
8. Sands, M. S., C. Vogler, A. Torrey, et al. 1997. Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation. J. Clin. Invest. 99:1596-1605.
9. Vogler, C., M. S. Sands, B. Levy, et al. 1996. Enzyme replacement with recombinant β-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth and survival. Pediatr. Res. 39:1050-1054.
10. O'Connor, L. H., L. C. Erway, C. A. Vogler, et al. 1998. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function. J. Clin. Invest. 101:1394-1400.
11. Daly, T. M., C. Vogler, B. Levy, et al. 1999. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc. Natl. Acad. Sci. USA 96:2296-2300.